 |
Ageing in Marfan Syndrome CME DisclosuresRelease Date: October 15, 2007; Valid for credit through October 15, 2008 |
| Physicians - maximum of 1.0 AMA PRA Category 1 Credit(s)™ for physicians | |
| Contents of This CME Activity | |
| Marfan's syndrome is a dominantly inherited connective tissue disorder caused by mutations in the fibrillin-1 gene, and primary clinical manifestations are in the ocular, cardiovascular, and musculoskeletal systems. In recent years, the life span of patients with Marfan's syndrome has increased, and more information is needed about the clinical problems faced by older patients with Marfan's syndrome. - Ageing in Marfan Syndrome
Ali Hasan, MD
Jan Poloniecki, MD
Anne Child, MD
Go to Test Questions |
| Legal Disclaimer | |
| The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity. Copyright © 2007 Medscape. |
|
|
 |
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Medscape, LLC designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Contact This Provider
|
|
